US 12,285,557 B2
Systems and methods for treating blood
Patrick Richard Spearman, The Woodlands, TX (US)
Assigned to HUMANITY LIFE EXTENSION LLC, Saint Paul, MN (US)
Filed by Humanity Life Extension LLC, Saint Paul, MN (US)
Filed on Nov. 20, 2020, as Appl. No. 16/953,558.
Application 16/953,558 is a continuation of application No. 16/214,807, filed on Dec. 10, 2018, granted, now 11,033,673.
Application 16/214,807 is a continuation in part of application No. 15/425,494, filed on Feb. 6, 2017, granted, now 10,946,134.
Application 15/425,494 is a continuation in part of application No. 14/623,455, filed on Feb. 16, 2015, granted, now 11,344,662.
Application 15/425,494 is a continuation in part of application No. 14/623,447, filed on Feb. 16, 2015, granted, now 10,773,012.
Claims priority of provisional application 62/011,451, filed on Jun. 12, 2014.
Claims priority of provisional application 61/983,752, filed on Apr. 24, 2014.
Claims priority of provisional application 61/940,628, filed on Feb. 17, 2014.
Prior Publication US 2021/0069402 A1, Mar. 11, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 1/36 (2006.01); A61K 33/26 (2006.01); A61K 45/06 (2006.01); A61M 1/14 (2006.01); A61M 1/16 (2006.01); A61M 1/32 (2006.01)
CPC A61M 1/369 (2013.01) [A61K 33/26 (2013.01); A61K 45/06 (2013.01); A61M 1/14 (2013.01); A61M 1/16 (2013.01); A61M 1/1698 (2013.01); A61M 1/32 (2013.01); A61M 1/36 (2013.01); A61M 1/3607 (2014.02); A61M 1/3621 (2013.01); A61M 1/3627 (2013.01); A61M 1/3633 (2013.01); A61M 1/3659 (2014.02); A61M 1/367 (2013.01); A61M 1/3672 (2013.01); A61M 1/3687 (2013.01); A61M 2202/0216 (2013.01); A61M 2202/0225 (2013.01); A61M 2202/0415 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3334 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3606 (2013.01); A61M 2205/366 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for treating cancer, comprising:
heating a human body to a core temperature between 42 and 43.2 degrees Celsius, wherein blood from the human body is flowing outside of the human body in a fluid flow path; and
removing carbon dioxide from at least a portion of the blood flowing in the fluid flow path such that the carbon dioxide level in the blood is between 35 and 60 mmHg.